학술논문

Subgroup analysis of phase 2 study of ceftolozane/tazobactam in neonates and young infants with pyelonephritis
Document Type
article
Source
Microbiology Spectrum, Vol 11, Iss 5 (2023)
Subject
ceftolozane/tazobactam
neonates
cUTI
young infants
pyelonephritis
Microbiology
QR1-502
Language
English
ISSN
2165-0497
Abstract
ABSTRACT Ceftolozane/tazobactam is approved for the treatment of patients from birth to